Vimta Labs Share Price
Small Cap | Pharmaceuticals and health care | NSE: VIMTALABS | BSE: 524394
₹924.45 -167.90 (-15.37 %)
Last Updated: 04 Apr 2025 03:54 PM
Overview
Open (₹) 1,094.20
High (₹) 1,096.65
Low (₹) 895.00
Prev. Close (₹) 1,092.35
Volume 4,32,472
VWAP (₹) 870.29
ROCE (%) 16.36
Industry P/E 64.34
TTM P/E 33.49
P/B Ratio 6.41
Market Cap (₹) Cr.2,055.47
Dividend Yield (%)0.22
EPS (₹) 18.24
ROE12.65%
Sales Growth (%) 0.02
Profit Growth (%)-14.87
Day Range
1,096.651,096.65
52 Week Range
420.001,183.00
Historical Returns
Returns (6M)
79.23 %
Returns (1Y)
96.46 %
Returns (3Y)
140.87 %
Returns (5Y)
1277.72 %
Returns (6M)
79.23 %
Returns (1Y)
96.46 %
Returns (3Y)
140.87 %
Returns (5Y)
1277.72 %
SWOT Analysis
- Company with Low Debt
- Book value per share improving over the last 2 years
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Increasing Revenue every Quarter for the past 4 Quarters
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 42.32
MFI 46.02
ATR 86.57
Commodity Channel Index -92.98
ROC125 42.37
ROC21 3.93
Williams %R -93.82
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 895.94 | 926.47 | 952.04 | 870.37 | 839.84 | 814.27 | 783.74 |
Week Ago | 976.11 | 1,005.48 | 1,026.06 | 955.53 | 926.16 | 905.58 | 876.21 |
Month Ago | 832.59 | 866.12 | 886.24 | 812.47 | 778.94 | 758.82 | 725.29 |
EMA & SMA
924.45
Current Price
Bullish Moving Averages
5
Bearish Moving Averages
15
5 Day 925.14
9 Day 941.86
10 Day 981.48
12 Day 991.04
14 Day 998.14
20 Day 961.32
26 Day 935.15
50 Day 945.45
100 Day 817.99
200 Day 674.83
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 29 Aug, 2024 | ₹638.01 | 1,44,647 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 29 Aug, 2024 | ₹638.65 | 1,44,647 | NSE |
XTX MARKETS LLP | bulk | Sell | 22 Jul, 2021 | ₹338.09 | 1,33,405 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 22 Jul, 2021 | ₹337.66 | 1,53,667 | NSE |
XTX MARKETS LLP | bulk | Buy | 22 Jul, 2021 | ₹338.22 | 1,25,571 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 22 Jul, 2021 | ₹338.02 | 1,53,667 | NSE |
XTX MARKETS LLP | bulk | Sell | 20 Jul, 2021 | ₹326.46 | 1,34,085 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 20 Jul, 2021 | ₹326.64 | 1,59,809 | NSE |
XTX MARKETS LLP | bulk | Buy | 20 Jul, 2021 | ₹325.64 | 1,37,824 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 20 Jul, 2021 | ₹326.66 | 1,59,809 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
17 Feb, 2025 | Harriman Vungal | Disposal | ₹1,083.66 | 2,900 | NSE |
12 Feb, 2025 | Harriman Vungal | Disposal | ₹ | 1,200 | NSE |
12 Feb, 2025 | Harriman Vungal | Disposal | ₹1,038.00 | 975 | NSE |
06 Dec, 2024 | Sujani Vasireddi | Disposal | ₹768.84 | 2,000 | NSE |
06 Dec, 2024 | Dhanya Prakash Dhumal | Disposal | ₹938.65 | 2,367 | NSE |
04 Dec, 2024 | Ravi Kumar Kunuguntla | Disposal | ₹853.11 | 2,018 | NSE |
27 Nov, 2024 | Suresh Kumar S | Disposal | ₹801.65 | 1,400 | NSE |
27 Nov, 2024 | Sujani Vasireddi | Disposal | ₹828.18 | 7,000 | NSE |
19 Nov, 2024 | Suresh Kumar S | Disposal | ₹743.33 | 1,500 | NSE |
19 Nov, 2024 | D R Narahai Naidu | Disposal | ₹767.35 | 3,659 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
21 May, 2024 | Rs.2.0000 per share(100%)Final Dividend | 11 Jul, 2024 | 01 Jan, 1970 |
03 May, 2023 | Rs.2.0000 per share(100%)Final Dividend | 21 Jun, 2023 | 01 Jan, 1970 |
12 May, 2022 | Rs.2.0000 per share(100%)Dividend | 16 Jun, 2022 | 18 Jun, 2022 |
Announcements
Date | Source | Detail |
---|---|---|
26 Mar, 2025 | NSE India | Vimta Labs Limited has informed the Exchange about Closure of Trading Window |
26 Mar, 2025 | NSE India | Vimta Labs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
20 Mar, 2025 | NSE India | Vimta Labs Limited has informed the Exchange regarding Allotment of Securities |
20 Mar, 2025 | NSE India | Vimta Labs Limited has informed the Exchange regarding Allotment of 11726 Shares. |
20 Mar, 2025 | BSE India | Allotment of Employee Stock Options under \ Vimta Labs Employee Stock Option Plan 2021- The ESOP Allotment Committee of the Board of Directors of the Company at their meeting held on 20th March,2025, has allotted 11726 equity shares of face value of Rs.2. |
05 Mar, 2025 | NSE India | Vimta Labs Limited has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
05 Mar, 2025 | NSE India | Vimta Labs Limited has informed the Exchange regarding Appointment of Siva Rama Krishna Kambhampati as Chief Financial Officer of the company w.e.f. March 06, 2025. |
05 Mar, 2025 | BSE India | Change in date of joining or appointment of Chief Financial Officer. The new date of joining is 6th March 2025. |
12 Feb, 2025 | BSE India | Clarification on Price Movement |
12 Feb, 2025 | NSE India | Significant movement in price has been observed in Vimta Labs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Vimta Labs Limited has submitted their response. |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 21 Jan, 2025 | 24 Jan, 2025 |
Quarterly Results | -- | 05 Nov, 2024 | 08 Nov, 2024 |
Quarterly Results | -- | 12 Jul, 2024 | 17 Jul, 2024 |
Audited Results & Final Dividend | -- | 10 May, 2024 | 18 May, 2024 |
Amalgamation | -- | 21 Mar, 2024 | 30 Mar, 2024 |
Quarterly Results | -- | 20 Jan, 2024 | 31 Jan, 2024 |
Quarterly Results | -- | 19 Oct, 2023 | 30 Oct, 2023 |
Quarterly Results | -- | 20 Jul, 2023 | 28 Jul, 2023 |
Audited Results & Final Dividend | -- | 25 Apr, 2023 | 03 May, 2023 |
Quarterly Results | -- | 16 Jan, 2023 | 27 Jan, 2023 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 36.76% | 36.98% | 37.25% | 37.46% | 37.46% |
Foreign Institutions + | 3.81% | 2.88% | 2.28% | 0.19% | 0% |
Domestic Institutions + | 1.15% | 1.49% | 2.13% | 1.92% | 0.11% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 58.28% | 58.65% | 58.34% | 60.43% | 62.43% |
Others | 0% | 0% | 0% | 0% | 0% |
About Vimta Labs
Vimta Labs is a Public Limited Listed company incorporated on 16/11/1990 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24110TG1990PLC011977 and registration number is 011977. Currently company belongs to the Industry of Medical Research Services. Company’s Total Operating Revenue is Rs. 312.89 Cr. and Equity Capital is Rs. 4.43 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1990
Managing Director
Ms. Harita Vasireddi
NSE Symbol
VIMTALABS
Vimta Labs Management
Name | Designation |
---|---|
Dr. Sivalinga Prasad Vasireddi | Executive Chairman |
Ms. Harita Vasireddi | Managing Director |
Mr. Harriman Vungal | Executive Director - Operations |
Mr. Satya Sreenivas Neerukonda | Executive Director |
Dr. Yadagiri R Pendri | Independent Director |
Ms. Prameela Rani Yalamanchili | Independent Director |
Mr. Sanjay Dave | Independent Director |
Mr. Purnachandra Rao Gutta | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Syngene International | ₹29,169.84 | ₹724.65 ₹747.15(-3.01%) | ₹608.000 - ₹960.000 |
Sun Pharma Advanced Research Company | ₹4,723.09 | ₹145.54 ₹150.00(-2.97%) | ₹109.200 - ₹474.000 |
Suven Life Sciences | ₹2,807.04 | ₹128.72 ₹131.41(-2.05%) | ₹83.270 - ₹169.000 |
Vimta Labs | ₹2,055.47 | ₹924.45 ₹1,092.35(-15.37%) | ₹420.000 - ₹1,183.000 |
Choksi Laboratories | ₹82.82 | ₹118.90 ₹123.40(-3.65%) | ₹46.010 - ₹142.400 |
FAQs on Vimta Labs
What is the share price of Vimta Labs?
The share price of Vimta Labs on 04 Apr, 2025 is ₹ 924.45.
What is 52W high and 52W low share price of Vimta Labs?
The highest and lowest 52W share prices of Vimta Labs are ₹ 1183.000 and ₹ 420.000
What is the market cap of Vimta Labs?
The market capitalization of Vimta Labs as of 04 Apr, 2025 is ₹ 2,055.47 Crores
What is the P/E ratio of Vimta Labs?
The current P/E ratio of Vimta Labs as of 04 Apr, 2025 is 64.34
What is the PB ratio of Vimta Labs?
The PB ratio of Vimta Labs as of 04 Apr, 2025 is 6.41
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)